Posted in | News | Drones and UAVs

Mobilicom Secures Design Wins for Cybersecure Drone and Robotics Solutions in Korea, Brazil, and Canada

Mobilicom Limited (Mobilicom or the Company), a provider of cybersecurity and robust solutions for drones and robotics, today announced design win sales into three new geographic markets including:

  • A Korean drone manufacturer has ordered Mobilicom’s newly designed and released MCU Maxi Controller PRO, a mobile, handheld Ground Control Station to be integrated and used with its drones.
  • A Brazilian manufacturer of robotics and unmanned ground vehicles ordered Mobilicom’s SkyHopper Datalinks for its small-sized robotics solutions.
  • A Canadian drone services provider in the oil, gas and mining industries also ordered Mobilicom’s SkyHopper Datalinks to distribute real time sensor feed from drones to on the ground users.

These orders bring Mobilicom’s design wins to a total of 48 as of June 30, 2023. Each design win represents initial sales of Mobilicom’s systems and components to be integrated into new autonomous systems designed by manufacturers of drones and robotics, many of which are Tier-1 companies. These design wins are expected to lead to commercial scale orders as manufacturers go to market with their uncrewed and autonomous vehicles.

“We are accelerating our momentum with these latest design wins and shipments to new key geographics markets and anticipate seeing more of our 48 design wins translate into commercial scale orders. This comes on the heels of our recently announced commercial scale order for our SkyHopper PRO from a Tier-1 U.S. manufacturer of drones for the U.S. Department of Defense,” stated Mobilicom CEO Oren Elkayam. 

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.